Lexicon Pharmaceuticals | Gewinn Vor Steuern



Pre Tax Profit Veränderung Datum
Abbott USD 1.78B 252M 2025-03
Acadia Pharmaceuticals USD 27.78M 133.31M 2025-03
Agios Pharmaceuticals USD -89289000 16.11M 2025-03
Alnylam Pharmaceuticals USD -41596000 152.36M 2025-03
AstraZeneca USD 3.4B 1.74B 2025-03
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Eli Lilly USD 3.46B 2.08B 2025-03
Halozyme Therapeutics USD 557.13M 359.8M 2024-12
Illumina USD 182M 47M 2025-03
Insmed USD -255671000 21.39M 2025-03
Ironwood Pharmaceuticals USD 17.37M 4.14M 2024-09
J&J USD 13.63B 8.21B 2025-03
MacroGenics USD -14477000 70.79M 2024-12
MannKind USD 13.62M 5.17M 2025-03
Merck USD 5.22B 114M 2024-12
Moderna USD -964000000 220M 2025-03
Novartis USD 4.66B 269M 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Sarepta Therapeutics USD -383518000 555.26M 2025-03
Thermo Fisher Scientific USD 2.63B 364M 2024-12
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
United Therapeutics USD 423.5M 27M 2025-03



Lexicon Pharmaceuticals Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.